An Avalere study suggested 340B duplicate discounts could increase as a result of Medicare drug price negotiations.

Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price

Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at